A pulmonary embolism is a blood clot lodged in the arteries of the lung.
It usually starts as a deep vein thrombosis (DVT) in the leg, breaks loose, travels through the heart, and gets stuck in the pulmonary arteries — blocking blood flow to part of the lung. Consequence ranges from minor to catastrophic.
A patient with an unprovoked PE who stops anticoagulation has roughly 10% recurrence in the first year and 30% by 5 years. A patient with a provoked PE (clear trigger, now resolved) has much lower recurrence — 3–5% at 5 years. Long-term anticoagulation reduces recurrence by 80–90%, with a tradeoff of bleeding risk.
Sudden shortness of breath is the most common symptom. Other classic features include sharp chest pain that worsens with breathing, rapid heart rate, cough (sometimes with blood), leg pain or swelling (from the source DVT), and in severe cases, dizziness, fainting, or sudden collapse. PE can also be silent — discovered incidentally on a CT scan ordered for another reason.
Suspicion is the first step. We use clinical decision tools like the Wells score to estimate the probability of PE. Low-probability patients get a D-dimer blood test; if negative, PE is effectively ruled out. Moderate or high-probability patients (and low-probability with elevated D-dimer) get a CT pulmonary angiogram (CTPA) — the imaging gold standard. Once PE is diagnosed, we assess severity with the Pulmonary Embolism Severity Index (PESI) and look for signs of right heart strain on echocardiogram or troponin. These determine whether outpatient treatment, inpatient treatment, or aggressive intervention (thrombolysis, catheter-directed therapy, surgery) is needed.
The mainstay is anticoagulation — direct oral anticoagulants (rivaroxaban, apixaban) for most patients, low-molecular-weight heparin for cancer-associated PE, warfarin in selected situations. Most patients are treated for 3 months minimum. Duration beyond 3 months depends on whether the PE was provoked or unprovoked. For severe PE with hemodynamic instability or massive clot burden, systemic thrombolysis or catheter-directed thrombolysis can dissolve the clot rapidly.
This page is general medical information, not personalized medical advice. If you have questions about your specific health, talk with your Nimbus clinician.